Signaling pathways
-
BA8196 PAT-505Summary: PAT-505 is a potent, selective, non-competitive orally available inhibitor. - BA8198 IrsenontrineSummary: Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 inhibitor.
- BA8199 PQ-10Summary: PQ-10 is a potent phosphodiesterase 10A inhibitor with sum values of 4.6 nM and 13 mg/kg, respectively.
- BA8200 CD00509Summary: CD00509 is an inhibitor.
- BA8201 PDE5-IN-4Summary: PDE5-IN-4 is a phosphodiesterase 5 inhibitor.
- BA8202 MotapizoneSummary: Motapizone (NAT05-239) is a selective inhibitor.
- BA8203 CI-1044Summary: An inhibitor.
- BA8204 ent-TadalafilSummary: ent-Tadalafil (ent-IC-351), compound (6S,12aS), is an inactive cis-enantiomer of compound (6R,12aS).
- BA8205 EnprofyllineSummary: Enprofylline is a selective and competitive receptor antagonist.
- BA8206 KuraridineSummary: Kuraridine is a keto-alcoholic extract obtained from bitter ginseng root.